|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows provided by operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of intangible assets | |||||
| Amortization of deferred contract costs | |||||
| Equity-based compensation | |||||
| Amortization of debt issuance costs | |||||
| Loss in extinguishment of debt | |||||
| Write-off of deferred offering costs | |||||
| (Recovery of) provision for bad debt expense | |||||
| Loss on partial extinguishment of debt | |||||
| Non-cash restructuring charges | |||||
| Goodwill impairment charges | |||||
| TRA remeasurement | |||||
| Changes in fair value of contingent consideration | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Deferred contract costs | |||||
| Contingent consideration | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows (used in) provided by investing activities: | |||||
| Purchases of property, equipment and other assets | |||||
| Purchases of short-term investments | |||||
| Maturities of short-term investments | |||||
| Cash paid for acquisitions and investments, net of cash acquired | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows (used in) provided by financing activities: | |||||
| Repayments of term loans | |||||
| Proceeds from term loan | |||||
| Payments of debt issuance costs | |||||
| Proceeds from equity offering, net of underwriting discounts | |||||
| Repurchase of outstanding equity / Definitive OpCo units | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Repurchases of Class A common stock | |||||
| Payments of contingent consideration | |||||
| Payments under TRA | |||||
| Payments of equity offering issuance costs | |||||
| Members contributions | |||||
| Member distributions | |||||
| Net cash used in financing activities | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental cash flow disclosures: | |||||
| Interest | |||||
| Income taxes | |||||
| Acquisitions: | |||||
| Net assets acquired, net of cash acquired | |||||
| Working capital adjustment receivable | |||||
| Initial cash investment in prior year | |||||
| Contingent consideration | |||||
| Net cash paid for acquisitions | |||||
| Supplemental disclosure of non-cash investing activities: | |||||
| Capital expenditures included in accounts payable and accrued expenses and other liabilities | |||||
| Supplemental disclosures of non-cash financing activities: | |||||
| Unpaid equity offering costs included in accrued expenses | |||||
Loading...